Manchester-based Kanichi Research has won an innovation competition that could see it revolutionise the diagnosis of diseases through a unique hand-held device which analyses the chemicals in a patient’s breath.
Kanichi Research entered Pera Technology’s Horizon 2020 innovation competition, which offered 10 companies the opportunity to win a free proposal submission to the European Commission’s SME Instrument.
The SME Instrument has a fund of €3 billion to support high-potential SMEs develop ground breaking ideas for products or processes that are ready to face global market competition.
Pera Technology has helped the company to apply for €50,000 under a Phase 1 funding application to the SME Instrument.
Phase 1 will provide Kanichi Research with a technical and commercial feasibility study, which will stand them in good stead to apply for a Phase 2 submission later on.
A successful Phase 2 submission could provide Kanichi Research with up to €5 million worth of funding to develop a platform technology which will detect chemicals in the breath that are linked to specific diseases, ultimately avoiding the delay and expense of samples being sent to analytical laboratories.
Craig Banks from Kanichi, said: “There has been considerable research into how chemicals in breath relate to diseases and disorders. A detection device will therefore speed up diagnosis and also negate the need for more invasive diagnosis methods.
“Our first target is to perfect the detection of ammonia which is shown to be associated with nine different medical conditions. We’re excited about the potential of this innovation and the proposal for funding through Horizon 2020.”